Patent · US Expired

Tricyclic compounds

US6211227A · kind A · utility

8Cited by
12References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 1999
Grant dateApr 3, 2001
Priority date
Expiry dateOct 14, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D337/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides tricyclic compounds which are useful for the treatment of pollakiuria and urinary incontinence and which are represented by general formula (I): ##STR1## (wherein PA1 R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, etc.; X.sup.1 --X.sup.2 --X.sup.3 represents CR.sup.5.dbd.CR.sup.6 --CR.sup.7.dbd.CR.sup.8 (wherein R.sup.5, R.sup.6, R.sup.7 and R.sup.8, which may be the same or different, each represents hydrogen, substituted or unsubstituted lower alkyl, hydroxy, substituted or unsubstituted lower alkoxy, etc.), N(O)m.dbd.CR.sup.5 --CR.sup.6.dbd.CR.sup.7 (wherein R.sup.5, R.sup.6 and R.sup.7 have the same significances as defined above, and m represents 0 or 1), S--CR.sup.7.dbd.CR.sup.8 (wherein R.sup.7 and R.sup.8 have the same significances as defined above), etc.; PA1 and when R.sup.2 represents hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkoxy, a substituted or unsubstituted N-substituted heterocyclic group, ##STR2## (wherein n is 0 or 1; R.sup.3 and R.sup.4, which may be the same or different, each represents hydrogen, substituted or unsubstituted lower alkyl, trifluoromethyl, etc.…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.